Home » Topics » BioWorld

BioWorld
RSS

EPITOPE SAYS RUMORS TRIGGERED STOCK SLIDE

June 16, 1992

BIOMIRA TO CONDUCT TESTS IN GERMANY

June 16, 1992

BIOCHEM PHARMA DEAL WITH AB ASTRA

June 16, 1992

APPLIED IMMUNE EXPANDS PHASE I TRIAL

June 16, 1992

ABC URGES BUSH TO SIGN REAUTHORIZATION BILL

June 15, 1992

FRIDAY'S STOCKS

June 15, 1992

FDA APPROVES TESTING OF SECOND SPECIFID

June 15, 1992

NO IMMUNOGENIC RESPONSE TO IMMURAID-CEA

June 15, 1992

APPOINTMENTS AND ADVANCEMENTS

June 15, 1992

ORGANOGENESIS EYES MARKETING OPTIONS

June 15, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...